Results 91 to 100 of about 15,144 (118)

Bridging B-cell autoimmunity and oncology: the PD-1/PD-L1 paradox in systemic lupus erythematosus. [PDF]

Front Immunol
Guan Y, Chen C, Hou Y.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Stimulation of B7-H1 in Hepatocarcinoma Cells by Hepatitis B virus X Antigen

Immunological Investigations, 2010
The cross-talk between the hepatitis B virus X protein (HBx) and B7-H1 in hepatocarcinoma (HCC) is unclear. This study analyzed the potential relationships between HBx and B7-H1 in hepatocarcinogenesis. One of human HCC cell lines, HepG2 cells, was transfected to stably express HBx protein (HBx(+)-HepG2).
Shengxi, Wu, Chengying, Yang, Sheng, Guo, Lei, Fei, Na, Luo, Xiaolan, Fu, Yongwen, Chen, Yuzhang, Wu   +7 more
openaire   +2 more sources

Potent Systemic Antitumor Immunity Induced by Vaccination with Chemotactic-Prostate Tumor Associated Antigen Gene-Modified Tumor Cell and Blockade of B7-H1

Journal of Clinical Immunology, 2006
We previously reported that several DNA fragments from human prostate-specific membrane antigen (hPSM), mouse prostatic acid phosphatase (mPAP), and human prostate-specific antigen (hPSA) genes were selected and fused to create a novel hPSM-mPAP-hPSA fusion gene (named 3P gene), and human secondary lymphoid tissue chemokine (SLC), 3P, and human IgG Fc ...
Ning, Li, Hanjun, Qin, Xiaozhu, Li, Chunxia, Zhou, Dongmei, Wang, Wenbo, Ma, Chen, Lin, Youhui, Zhang, Shengdian, Wang, Shuren, Zhang   +9 more
openaire   +2 more sources

Blockade of PD-1/B7-H1 interaction restores antigen-specific CD8+ T cell responses in HCV core transgenic mice (47.8)

The Journal of Immunology, 2007
Abstract Impaired CD8+ T cells have been implicated to play a role in the establishment of HCV persistent infection. HCV has evolved multiple strategies to avoid T cell responses. HCV core protein has been shown to contain immunomodulatory functions.
John R Lukens, Young S Hahn
openaire   +1 more source

TLR 7/8 agonist resiquimod alleviates murine allergic asthma through IL-27 production and up regulation of B7-H1 on antigen presenting cells

5.3 Allergy and Immunology, 2015
Background: Counter balancing Th2-cytokine production through enhanced skewing of CD4+ T helper cells into Th1 cells is currently one of the central immunomodulatory approaches for treatment of allergic diseases. Methods: We systemically sensitized mice followed by intranasal challenge with the model allergen.
Kathleen Daluge, Adan Chari Jirmo, Mandy Busse, Gesine Hansen   +3 more
openaire   +1 more source

Abstract 2935: Modulation of immune checkpoint B7-H1/B7-DC/PD-1 interaction in combination with live attenuated Listeria monocytogenes expressing a tumor associated antigen effectively treats hepatic colorectal cancer metastases

Cancer Research, 2010
Abstract Introduction: The successful eradication of tumor deposits by immunotherapy requires the generation of an appropriate primary and memory immune effector immune response as well as the establishment of a tumor micro-environment within that organ to target, traffic and amplify the appropriate immune response. B7-H1 is expressed on
Kiyoshi Yoshimura, Kelly Olino, Barish Edil, Satoshi Wada, Xiaoyu Pan, Kristen Meckel, Drew Pardoll, Richard Schulick   +7 more
openaire   +1 more source

QS157. Antigen Presenting Cell B7-H1 and T Cell PD-1 are Increased in Human Hepatocellular Carcinoma: Evidence for Increased Immune Regulation

Journal of Surgical Research, 2009
T.H. Welling, K. Wu, I. Kryczek, W. Zou
openaire   +1 more source

Faculty Opinions recommendation of B7-H1-expressing antigen-presenting cells mediate polarization of protumorigenic Th22 subsets.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature, 2014
Philippe Saas, Sylvain Perruche
openaire   +1 more source

Critical care management of chimeric antigen receptor T‐cell therapy recipients

Ca-A Cancer Journal for Clinicians, 2022
Alexander Shimabukuro-Vornhagen, Boris Boll, Sandrine Valadè   +2 more
exaly  

Chimeric antigen receptor T‐cell therapy in multiple myeloma: A comprehensive review of current data and implications for clinical practice

Ca-A Cancer Journal for Clinicians, 2023
Rujul H Parikh, Sagar Lonial
exaly